HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 644 | 754 | 85.4% | |
| HF 4 | 2011 | 658 | 769 | 85.6% | |
| HF 4 | 2012 | 734 | 867 | 84.7% | |
| HF 4 | 2013 | 765 | 891 | 85.9% | |
| HF004(S) | 2014 | 438 | 492 | 89.0% | |
| HF004(S) | 2015 | 505 | 562 | 89.9% | |
| HF004(S) | 2016 | 572 | 637 | 89.8% |
